Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors. [electronic resource]
Producer: 20070220Description: 2090-5 p. digitalISSN:- 0885-3185
- Analysis of Variance
- Animals
- Antiparkinson Agents -- therapeutic use
- Behavior, Animal -- drug effects
- Callithrix
- Disease Models, Animal
- Dopamine Antagonists -- therapeutic use
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Indoles -- therapeutic use
- Levodopa -- therapeutic use
- MPTP Poisoning -- drug therapy
- Motor Activity -- drug effects
- Oxazines -- therapeutic use
- Piperidines -- therapeutic use
- Receptors, Dopamine D2 -- physiology
- Receptors, Dopamine D3 -- physiology
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.